Analysts believe BP needs to sell Castrol at an enterprise value of $12bn if the deal is to improve the company’s free cash flow, but have questioned whether the company can obtain such a price given ...

The Financial Times highlights key developments, including bidders undervaluing BP's Castrol, AstraZeneca's promising breast ...

These are the most popular stories from the Financial Times. These stories have not been verified and we cannot vouch their accuracy.